SeptRx
United states-based medical device company developing minimally invasive treatments for structural heart defects.
Launch date
Employees
Market cap
-
Enterprise valuation
€10—15m (Dealroom.co estimates Jun 2011.)
Fremont California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$2.7m | Series A | ||
| Total Funding | €2.5m | ||
Recent News about SeptRx
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.